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Abstract
Objective—To determine whether genetic variants associated with diabetes and obesity predict
gestational weight gain.
Study Design—960 participants in the Pregnancy, Infection and Nutrition cohorts were
genotyped for 27 single-nucleotide polymorphisms (SNPs) associated with diabetes and obesity.
Results—Among white and black women (n=960), KCNQ1 risk allele carriage was directly
associated with weight gain (p < 0.01). In Bayesian hierarchical models among white women
(N=628), we found posterior odds ratios > 3 for inclusion of TCF2 and THADA SNPs in our
models. Among black women (n=332), we found associations between risk allele carriage and
weight gain for the THADA and INSIG2 SNPs. In Bayesian variable selection models, we found
an interaction between the TSPAN8 risk allele and pre-gravid obesity, with lower weight gain
among obese risk allele carriers.
Conclusion—We found evidence that diabetes and obesity risk alleles interact with maternal
pre-gravid BMI to predict gestational weight gain.
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Introduction
Maternal weight gain during pregnancy is an important predictor of health outcomes for
both mother and child1. Inadequate gestational weight gain is associated with preterm birth2,
intrauterine growth restriction, low birth weight, and offspring obesity risk3, whereas
mothers who gain excessively are more likely to deliver by cesarean section 4–7, have an
unsuccessful trial of labor after c-section8, develop pre-eclampsia6, retain excessive weight
after delivery9, 10, and become overweight or obese in later life11, 12. Infants born to women
who gain excessively during pregnancy are more likely to be born preterm13, be macrosomic
at birth (> 9 lbs)5, 14, 15, and become overweight or obese as toddlers16 and adults3. Based
on these well-described epidemiologic associations, gestational weight gain has been
targeted as a modifiable risk factor for metabolic disease in both mother and child.
While intervention strategies have targeted health behaviors that affect gestational weight
gain, a mother’s genotype is also likely to influence her pattern of weight gain. Recent
studies in non-pregnant populations have identified common genetic variants associated
with diabetes and obesity. Family and twin studies suggest that 50% of obesity is
attributable to genetic causes17. In a recent multicenter study, subjects homozygous for the
FTO rs9939609 A allele had a 1.6-fold increased risk of obesity18. Variants in MC4R19 and
INSIG220, as well as multiple gene regions recently identified by the GIANT consortium21,
are also associated with body mass index (per-allele effect 0.06–0.33 kg/m2). In addition,
association studies have identified common genes associated with type 2 diabetes22–26, such
as PPARG and TCF7L2.
Elucidating the role of genetic variants in gestational weight gain has important implications
for public health. If genetic variants associated with diabetes and obesity are also linked with
inappropriate weight gain, then excessive or inadequate gain may a marker for genetic
predisposition to metabolic disease. No studies to our knowledge have measured the
association between genetic variants associated with diabetes and obesity and gestational
weight gain. We hypothesized that such genetic variants predict a mother’s total weight gain
during pregnancy. We further hypothesized that a woman’s complement of diabetes and
obesity risk alleles predicts whether she will gain in excess of IOM guidelines. Finally, we
hypothesized that genotype modifies the association between pregravid BMI and gestational
weight gain. To test these hypotheses, we measured such associations in a subset of women
enrolled in the Pregnancy, Infection and Nutrition Study, 1998–2005, a longitudinal
pregnancy cohort study.
Materials and Methods
The Pregnancy, Infection and Nutrition Cohort study comprises three prospective cohorts of
more than 5000 women enrolled in early to mid-pregnancy. Participants enrolled in PIN1
and PIN2 were 24–29 weeks gestation at study entry, and were recruited from University of
North Carolina Resident and Private Physician Obstetrics Clinic and the Wake County
Department of Human Services and Wake Area Health Education Center prenatal care
clinics from August 1995 through June 2000. Subjects enrolled in PIN3 were less than 20
weeks gestation at study entry and were recruited from the prenatal clinics at UNC hospitals
from January 2001 to June 2005.
Extracted DNA was available for 1363 pregnancies that had undergone prior genotyping for
case:control studies of preterm birth, small-for-gestational age birth weight, and placental
vascular disease (Figure 1). For 132 pregnancies, there was insufficient DNA available for
genotyping, leaving 1231 pregnancies eligible for our study. We allowed for only one
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pregnancy during the study period. If data were available for multiple pregnancies (N=21),
we confirmed that the genotypes were concordant and included the pregnancy with the most
complete SNP data. One pair of specimens was not concordant, so this subject was
excluded. We further limited our analysis to self- identified black (n = 418) or white (n =
756) women, in order to avoid confounding by population stratification. As we considered
ancestry, we removed women missing more than 20% of ancestral data (n = 61). We further
removed black women for whom ancestry informative markers indicated a less than 10%
probability of Yoruban ancestry (n = 3). Finally, we excluded women who were missing
data on gestational age (n = 63), gestational weight gain (n = 64) or pre-gravid BMI (n =12,
total removed = 149), leaving 960 women available for analysis (Figure 1).
Determination of pre-gravid BMI
Pre-gravid BMI was calculated based on self-reported pre-gravid weight and height at the
first prenatal visit. Self-reported pre-gravid weights were examined for biological
plausibility and imputed if deemed appropriate (<5% of weights were imputed). This
imputed weight was calculated using the measured weight at the first prenatal visit (if taken
prior to 15 weeks) minus the recommended amount of weight to be gained in the first and
second trimesters as defined by the Institute of Medicine{Institute of Medicine, 1990
#1097}27.
Study covariates
The PIN datasets include information from telephone interviews, self-administered
questionnaires, medical chart abstraction, and biological specimen collection. Information
on race/ethnicity (non-Hispanic white, non-Hispanic black, and other) and maternal age was
self-reported by the mother. Gestational age was estimated based on an algorithm that
combined ultrasound dating with last menstrual period. If an ultrasound was done before 22
weeks gestation, it was used to date the pregnancy. If no ultrasound was done or it was done
later in pregnancy, last menstrual period was used to date the pregnancy. In the PIN cohorts,
90.7% had an ultrasound that was used to date the pregnancy with the remaining 9.3% based
on LMP.
Outcome assessment
Clinically obtained weights were recorded at each prenatal visit. We calculated gestational
weight gain as the difference between pre-gravid self-reported weight and the last weight
prior to delivery. We defined excessive or inadequate weight gain based on the 1990
Institute of Medicine (IOM) recommendations28; these were as follows: 28 to 40 lbs for low
BMI (<19.8), 25–35 lbs for normal BMI (19.8 to 26.0), 15 to 25 lbs for overweight BMI
(>26 to 29) and at least 15 pounds of gain for obese BMI (> 29). The IOM did not specify an
upper limit for this group. For purposes of this analysis, excessive gain in the obese group
was defined as greater than 18 lbs of gain, consistent with other analyses in the PIN cohorts.
To calculate adequacy of gain for any given time point in pregnancy, the upper and lower
limits of the weight gain intervals were extrapolated based on IOM-recommended rates of
weight gain for the second and third trimesters29, consistent with earlier studies in this
cohort30–32.
Genotyping
The Sequenom iPLEX platform33 was used to genotype 27 SNPs associated with obesity
and diabetes19, 21–26, 34. For the purpose of quality control, 6 SNPs that had been previously
assessed in the PIN cohorts were also genotyped. All SNPs were tested for Hardy-Weinberg
equilibrium among self-identified white participants.
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Population stratification
In genetic association studies, differences in allele frequency among ethnic groups can
confound relationships between genotype and disease outcome. To address population
stratification in this cohort, genotyping was performed for 37 ancestry-informative markers
that have been successfully in other genetic association studies35. STRUCTURE was used to
infer population substructure and assign individuals to populations using probabilistic
clustering methods36. We analyzed self-identified white and black participants separately,
and we included probability of Yoruban ancestry as a covariate among self-identified black
women.
Statistical analysis
The DNA used for this study had been extracted for previous case:control studies of SGA,
preterm birth and placental vascular disease, so prevalence of these outcomes was high. In
order to produce estimates of the association between genotype and outcome that would
approximate what we would have observed for the full study cohort, we calculated the
probability of each participant’s inclusion in our study population. We used inverse
probability weights to adjust our findings in all regression analyses. We used the SAS 9.2
surveylogistic and surveyreg for these analyses.
We used linear regression to model associations between maternal genotype and total
gestational weight gain, adjusting for maternal age, linear and quadratic gestational age at
birth, as well as probability of Yoruban ancestry among self-identified black women. We
similarly used logistic regression to model associations between maternal genotype and
probability of excessive gestational weight gain. We did not include in our models
reproductive and obstetric factors that may be affected by genotype and may also affect
weight gain, such as gestational diabetes and preeclampsia. These factors are potential
intermediates on the causal pathway between genotype and weight gain, and including them
in our models would attenuate the true association between maternal genotype and the
outcome of interest. Moreover, because genotype may impact parity, we did not include
parity as a covariate in our models.
We next considered models incorporating pre-gravid BMI in addition to gestational age and
maternal age. Because the association between pre-gravid BMI and gestational weight gain
is non-linear, both linear and quadratic terms were included. We then used hierarchical
selection to model 1) Quadratic models including the joint effects of SNP allele carriage and
interactions between SNP carriage and both log BMI and log BMI squared; 2) Linear
models including the effects of SNP carriage and interactions between SNP carriage and log
BMI; and 3) main effect models including only SNP allele carriage. If the Wald chi square p
value for model 1 was < 0.05, the wald chi square p value for the quadratic interaction term
was determined. If this was < 0.1, then the quadratic interaction term was retained. We
similarly evaluated the linear model, retaining the interaction term if the SNP and SNP * log
BMI p was < 0.05 and the SNP * log BMI term was < 0.1. Finally, we retained the main
effects model if the p for the SNP term was < 0.05. To avoid false-positive findings due to
small cell sizes, we excluded SNPs with fewer than 5 homozygous low or high-risk allele
participants from these interaction models.
We did not to adjust alpha levels for multiple comparisons in this analysis. We recognize
that this approach is may produce false positive associations. However, the purpose of our
pilot study was to investigate the strength and direction of associations between these
diabetes and obesity SNPs and gestational weight gain. All results should be viewed as
exploratory findings pending confirmation in larger cohorts.
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We next considered the simultaneous effects of multiple SNPs, using Bayesian models. For
these analyses, we analyzed the data for subjects with complete information on genotypes
using additive parameterization for SNPs. We used linear regression with gestational weight
gain as the response variable, and SNP carriage, obesity and their interactions as covariates,
adjusting for maternal age, linear and quadratic terms for gestational age at birth, and
probability of Yoruban ancestry among self-identified black women. We avoided using a
model with interactions between SNPs and log(BMI), log(BMI) squared as it would lead to
a much larger model space and induce high correlations in the design matrix. The Bayesian
variable selection framework allows each covariate to be either included or excluded from
the model with a pre-assigned prior probability, which we chose as 0.5. After observing the
data, the idea is to search over the list of all models, which includes models with no
covariates, 1 covariate, …., all covariates, to identify the models which explain the observed
data the best. With our choice of prior distributions, the prior odds ratio of including a
covariate versus excluding is 1. We report the covariates with posterior (after observing the
data) odds ratios greater than 3.
Results
Of the 79 SNPs genotyped, 71 genotyped for more than 90% of samples and were in Hardy-
Weinberg equilibrium for the self-described White/Caucasian population. We anticipated
that some SNPs would not be in HWE for African American participants due to admixture
within African American populations in the US, and we found that one diabetes SNP and 4
of 37 ancestry-informative marker SNPs were not in HWE in this group. Our results were
99.5% concordant for SNPs that had previously been genotyped in the PIN cohort.
Compared with white participants in our cohort, African American women were younger,
had slightly higher pre-gravid BMIs, lower gestational weight gain and lower birth weight
infants than Caucasian women (Table 1).
In linear regression analyses adjusted for maternal age and gestational age at birth and
weighted to reflect the full PIN study population, we found associations between risk-allele
carriage and gestational weight gain for several diabetes-associated variants (Table 2, Figure
1a and b). The KCNQ1 risk allele was associated with higher gestational weight gain
(Caucasian 1 risk allele: 2.8 kg, 95% CI 0.4–5.1; 2 risk alleles: 2.9 kg, 95% CI 1.3 to 4.6;
African American 1 risk allele: 3.4 kg, 95% CI 0.6 to 6.3; 2 risk alleles: 2.7 kg, 95% CI 0.5
to 4.8). Among Caucasian participants, PPARG risk allele carriage was associated with
lower gestational weight gain (1 risk allele: −7.9 kg, 95% CI −15.4 to −0.4; 2 risk alleles:
−7.6 kg, 95% CI −15.1 to −0.2). No African American participants were homozygous for
the low-risk PPARG variant.
We found different patterns of association for Caucasian and African American participants
for several other diabetes-associated SNPs (Table 2, Figure 2a and 2b). Among Caucasian
participants, we further identified associations between gestational weight gain and
CKDAL1 as well as TSPAN8. Among African American participants, we found associations
between gestational weight gain and CDKAL1, CDKN2A2B, KCNJ11, SLC30A8, CDC123,
and THADA.
In our adjusted models for obesity-related risk variants (Table 2, Figure 3), we found higher
gestational weight gain for African American participants with 2 MC4R risk alleles (3.8 kg,
95% CI 0.01 to 2.9), compared with women with no MC4R risk alleles. We found no other
consistent patterns of association between obesity risk variants and gestational weight gain
among African-American women, although individuals with one risk allele for INSIG2 had
higher weight gain than women with 0 or 2 risk alleles. In contrast to our findings for MC4R
among African American women, among Caucasian women, MC4R carriage was inversely
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associated with weight gain (1 risk allele: −0.7 kg, 95% CI −1.7 to 0.3; 2 risk alleles: −1.6
kg, 95% CI −3.6 to 0.4), although confidence intervals were wide.
In logistic regression models of associations between diabetes SNPs and excessive
gestational weight gain (Table 3, Figure 4a and 4b), we found higher risks for excessive gain
among Caucasian participants with 2 copies of the TCF2 risk allele (OR 1.8, 95% CI 1.1–
3.0, vs. 0 copies of the risk allele) or 2 copies of the G6PC2 risk allele (OR 2.4, 95% CI 1.1–
5.0), and lower risks among participants with 2 copies of the TSPAN8 risk allele (OR 0.4,
95% CI 0.2–0.8, vs. 0 copies). Among African American participants, NOTCH2 risk allele
carriage was associated with reduced risk for excess gain (OR for 1 risk allele 0.5, 95% CI
0.3–0.9; OR for 2 risk alleles, 0.5, 95% CI 0.2–1.1, vs 0 risk alleles). THADA risk allele
carriage was also associated with less excessive gain (OR for 1 risk allele 0.2, 95% CI 0.1–
0.8, and for 2 risk alleles, 0.3, 95% CI 0.1–0.9, vs. 0 risk alleles), but confidence intervals
were wide. SLC30A8 risk allele carriage was associated with markedly increased excessive
weight gain, but there were only 3 participants with 0 risk alleles in our study population,
leading to imprecise effect estimates.
In our analysis of obesity SNPs and excessive weight gain (Table 3, Figure 5), carriage of
one copy of the MTCH2 risk allele was associated with excessive gain among YRI
participants (OR 3.1, 95% CI 1.5–6.5, vs 0 risk alleles). There were no statistically
significant associations between obesity risk allele carriage and excessive weight gain risk
among CEU participants (Figure 5).
We found interactions between risk allele carriage and pre-gravid BMI for TCF7L2, TCF2,
CDKAL1, THADA, ADAMTS9, NOTCH2, FTO and TMEM18, as well as main effects for
TSPAN8 (Figure 6). Among African-American participants, we found interactions between
risk allele carriage and pre-gravid BMI for WFS1, ADAMTS9, TMEM18 and MTCH2 and
main effects for THADA and INSIG2 (Figure 7).
Finally, we used Bayesian variable selection models to test the additive effect of multiple
SNPs on gestational weight gain. Among Caucasian women, we found a posterior odds ratio
> 3 for greater weight gain with carriage of the TCF2 risk allele (1.1 kg per allele, 95% CI 0
to 2.7, posterior OR 4.0) and for lower weight gain among obese women carrying the
THADA risk allele (−1.7 kg per allele, 95% CI −4.2 to 0.07, posterior OR 4.26). Among
African-American women, we found a posterior odds ratio >3 for an interaction between the
TSPAN8 risk allele and obesity, with lower weight gain among obese risk allele carriers
(−2.4 kg per allele, 95% CI −6.7 to 0.3, posterior OR 3.2).
Comment
In this prospective longitudinal study of pregnant women, we found several associations
between diabetes and obesity SNPs and gestational weight gain. The effect of risk allele
carriage varied with pre-gravid body mass index, suggesting that genotype may modify the
effect of a woman’s body composition prior to pregnancy on weight gain trajectory.
Our findings confirm and extend earlier work on associations between diabetes and obesity
SNPs and weight trajectory. We found greater weight gain among women with the Ala12Ala
PPARG genotype than those with Pro12Pro genotype, although the number of Ala12Ala
participants was small (N=7), and our findings may be sensitive to two of the seven
Ala12Ala participants with weight gains of 28 and 40 kg. In a small study of women with
gestational diabetes (N=62), Tok et al found greater weight gain among women with the
Pro12Ala genotype than women with the Pro12Pro genotype. PPARG is expressed
primarily in adipocytes, and this gene appears to regulate triglyceride storage in adipose
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tissue37–39. It is plausible that Ala12Ala carriers have increased capacity for triglyceride
storage, leading to greater gestational weight gain.
We also found greater gestational weight gain among women with one or two copies of the
KCNQ1 risk allele, compared to homozygous low-risk women, although the number of low-
risk homozygotes was low (4 Caucasian women and 2 African-American women). The low-
risk KCNQ1 rs2237892 variant has been associated with increased c-peptide levels at 30
minutes after oral glucose load 40. It is plausible that more efficient insulin release lowers
postprandial glucose concentrations and thus reduces gestational weight gain.
Among African-American participants, we found greater weight gain among MC4R high-
risk homozygotes. The MC4R rs17782313 variant is associated with increased energy
intake, increased total fat and protein intake, and greater weight gain over time in the
predominantly-Caucasian Nurses’ Health Study cohort41. Interestingly, MC4R risk allele
carriage was not associated with obesity among African-American children in a large
case:control study42.
We also found interactions between pre-gravid BMI and genotype for several diabetes and
obesity risk alleles in our population. These results suggest that a woman’s pre-gravid BMI
as well as her genotype influence gestational weight gain. For example, in analyses of FTO
rs9939609 risk allele carriage among Caucasian women, thin or obese women homozygous
for the high risk allele gained more weight than low-risk allele carriers, but among women
of average pre-gravid BMI, weight gain was similar regardless of allele carriage. These
results suggest that it may be important to consider baseline BMI in longitudinal studies of
genetic determinants of weight trajectory.
Our results must be interpreted within the context of the study design. Strengths of this study
include our prospective collection of gestational weight gain data and the use of ancestry
informative markers to adjust for population stratification. In addition, we used innovative
techniques to model the role of pre-gravid BMI in modifying the effect of genotype on
pregnancy phenotype. Our study also has several limitations. This is a secondary analysis of
data collected over a 10-year period, and secular changes in medical recommendations, diet
and physical activity, as well as the evolving nature of the PIN studies, may have modified
the association between genotype and weight gain. Bias is also a concern, because we used
samples from a subset of a larger cohort. Our use of sampling weights allowed us to produce
estimates that approximate what we may have observed from a complete data set, but we
were unable to adjust for the possibility that a woman’s willingness to allow genetic analysis
or provide a blood sample may be non-random. Moreover, this is a pilot study, and our
sample size was small, reducing our ability to detect differences among women with
differing genotypes. In GWAS studies of obesity risk alleles and body mass index, risk
allele carriage has been associated with differences of 0.10 to 0.33 kg/m221, which are
considerably smaller than what we could detect in our population. In addition, pregnancy
weight gain was measured in a clinical setting, without assessment of water weight vs.
adipose tissue. Associated measurement error may further reduce our power to detect
associations between genotype and outcome. At the same time, multiple testing is a concern.
To address this issue, we limited our analysis to candidate SNPs that have been validated in
multiple large studies. Nevertheless, we recognize that some of our findings may be false
positives. With 18 diabetes SNPs and 2 comparisons for each SNP, we would expect to find
1.8 significant associations by chance alone, and with 9 obesity SNPs, we would expect to
find 0.9 significant association by chance alone, if we conservatively assume independence
of all SNPs.
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In conclusion, we found evidence that maternal diabetes- and obesity-risk allele genotype
interact with pre-gravid BMI to affect gestational weight gain. These results suggest that
excessive or inadequate gain may be marker for maternal genotype, and these differences in
genetic risk may explain some observed associations between gestational weight gain and
long term health outcomes for mothers and infants. Further studies in larger cohorts will be
needed to delineate further the role of genotype in maternal weight gain during pregnancy.
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Figure 1. Flow diagram
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Figure 2. a and 2b: Diabetes-associated SNPs and gestational weight gain
Multivariate-adjusted§ effect estimate (95% CI) for change in gestational weight gain
associated with risk allele carriage for single nucleotide polymorphisms associated with
diabetes in non-pregnant populations. Caucasian participants (n=628) on left, African-
American participants (n=332) on right.
* p < 0.05 for partial F test for this SNP. # p < 0.05 for comparison with 0 risk alleles
(referent).
§ Model covariates include log pregravid BMI, log pregravid BMI squared, gestational age
at birth, gestational age at birth squared, and maternal age. Effect estimates among self-
identified African American participants further adjusted for probability of Yoruban
ancestry. All models weighted to reflect the composition of the full PIN studies population.
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Figure 3. Obesity-associated SNPs and gestational weight gain
Multivariate-adjusted§ effect estimate (95% CI) for change in gestational weight gain
associated with risk allele carriage for single nucleotide polymorphisms associated with
obesity in non-pregnant populations. Caucasian participants (n=628) on left, African-
American participants (n=332) on right.
* p < 0.05 for comparison with 0 risk alleles (referent).
§ Model covariates include log pregravid BMI, log pregravid BMI squared, gestational age
at birth, gestational age at birth squared, and maternal age. Effect estimates among self-
identified African American participants further adjusted for probability of Yoruban
ancestry. All models weighted to reflect the composition of the full PIN studies population.
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Figure 4. a and 4b: Diabetes-associated SNPs and excessive gestational weight gain
Multivariate-adjusted§ odds ratio (95% CI) for excessive weight gain by risk allele carriage
for single nucleotide polymorphisms associated with diabetes in non-pregnant populations.
Caucasian participants (n=628) on left, African-American participants (n=332) on right.
* p < 0.05 for Wald Chi Square test; # p <0.05 for comparison with 0 risk alleles (referent).
§ Model covariates include log pregravid BMI, log pregravid BMI squared, and maternal
age. Effect estimates among self-identified African American participants further adjusted
for probability of Yoruban ancestry. All models weighted to reflect the composition of the
full PIN studies population.
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Figure 5. Obesity-associated SNPs and excessive gestational weight gain
Multivariate-adjusted§ odds ratio (95% CI) for excessive weight gain by risk allele carriage
for single nucleotide polymorphisms associated with obesity in non-pregnant populations.
Caucasian participants (n=628) on left, African-American participants (n=332) on right.
* p < 0.05 for Wald Chi Square test; # p <0.05 for comparison with 0 risk alleles (referent).
§ Model covariates include log pregravid BMI, log pregravid BMI squared, and maternal
age. Effect estimates among self-identified African American participants further adjusted
for probability of Yoruban ancestry. All models weighted to reflect the composition of the
full PIN studies population.
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Figure 6. Interactions between pre-gravid BMI and SNP carriage, Caucasian participants
Multivariate-adjusted§ mean predicted gestational weight gain as a function of body mass
index and risk allele carriage among self-identified Caucasian participants, N=628.
§ Model covariates include log pregravid BMI, log pregravid BMI squared, and maternal
age. All models weighted to reflect the composition of the full PIN studies population.
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Figure 7. Interactions between pre-gravid BMI and SNP carriage, African-American
participants
Multivariate-adjusted§ mean predicted gestational weight gain as a function of body mass
index and risk allele carriage among self-identified African-American participants, N=332.
§ Model covariates include log pregravid BMI, log pregravid BMI squared, and maternal
age, and probability of Yoruban ancestry. All models weighted to reflect the composition of
the full PIN studies population.
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Table 1
Characteristics of participants in the PIN3 study, n=960, mean (SD).
Caucasian African American
N 628 332
Maternal age 27.7 (6.2) 23.9 (5.3)
Pregravid BMI, kg/m2 25.0 (6.6) 27.4 (8.1)
GA at delivery, wks 40.1 (0.9) 39.9 (1.1)
Infant birth weight, g 3258 (672) 2939 (753)
Gestational weight gain, kg 15.3 (6.2) 13.4 (7.8)
Glucose loading test, mg/dL 108.4 (25.9) 105.6 (31.0)
Gestational diabetes, % (n) 7.2 (45) 5.7 (19)
Small-for-gestational age, % (n) 12.3 (77) 18.7 (62)
Birth<37 wks, % (n) 21.2 (133) 28.0 (93)
Excessive weight gain, % (n) 65.5 (411) 58.4 (194)
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